Caliper license deal ends AntiCancer patent suit (BizJournals)
Caliper license deal ends AntiCancer patent suit (BizJournals)
Caliper Life Sciences Inc. reports it has ended patent litigation between the scientific research products firm and AntiCancer Inc. via a cross-licensing deal.